Pharmacy News | December 2023

Modiplus • December 4, 2023

Welcome to the winter edition of our quarterly newsletter


The future of community pharmacy

Nobody knows the future of community pharmacy and the right time to sell. As always, you should consider selling when there is no threat to your business that will affect its goodwill. You might decide to sell due to retirement, ill health or you are going into a new venture. We have seen goodwill values drop in the last 12 months or so due to corporate disposals and other distressed sales flooding the market. But it’s not all gloom and doom as equally, we have been extremely busy completing many deals over the last quarter. Most of the transactions have been to first time buyers, independents, small and medium size groups with a forward-looking plan to grow while the large multiples downsize.


We believe next year will present a good opportunity to exit, if you are looking to sell the business, as interest rates start to fall, cost of living crisis abate, and the banks start to lend proactively again.


Pharmacy First service

This service will launch on 31 January 2024 which will be a new advanced service and will replace the Community Pharmacist Consultation Service (CPCS). The pharmacies will receive a first initial fixed payment of £2,000 that can be claimed from December 2023 and a monthly fixed payment of £1,000 from February 2024 for pharmacy contractors who reach a minimum number of monthly clinical pathway consultations (from 1 consultation in February 2024 to 30 consultations from October 2024).


Community pharmacists should seize the opportunity and provide maximum amount of services that they possibly can, to increase sales and profits to mitigate the cost increases of the last couple of years. This will also increase the value of the business.


The Pharmacy Show 2023

The Pharmacy Show returned to the NEC Birmingham on 15th and 16th October 2023. Over the course of two days, there were over 8,500 pharmacy professionals attending the show and over 300 exhibitors. A highlight of the show, an automation system (robotic) whereby even a small pharmacy

can invest into one model for hub and spoke which was previously only an option for larger groups. There is a whole host of affordable options that will allow you to automate those everyday tasks such as dispensing medication and managing stock levels etc.


Our joint stand with Silver Levene was located next to the Business Theatre where some excellent speakers with thought provoking ideas commented on the future of the pharmacy and new funding. Whilst exhibiting, we had numerous enquiries on selling and buying a pharmacy as well as pharmacists looking for an accountancy and tax advice. The show was a success, and we look forward to exhibiting again next year, our 17th year bar the covid years.


Pharmacy Valuations

If you are thinking of selling your pharmacy, we advise that you seek professional advice and valuation from a pharmacy expert or pharmacy sales agent. The valuation is determined by several factors to name but a few as a reminder: -

  • EBITDA (Earnings before interest, tax, depreciation, and amortisation) profits – this is a preferred measure to value pharmacies and bank’s valuer will do the same.
  • Financial information – Accounts, FP34s, VAT returns should be up to date.
  • Location – pharmacies located in a health centre or next door to a surgery will still fetch abetter price, if there is more footfall too.
  • Lease and rent – ensure there is at least 10 years left on the lease and is renewable. A very high rent will be a detriment to sale, buyers will account for any future rent and increases.
  • Staff costs – high staff and locum costs will reduce the value of the pharmacy.
  • NHS/OTC/services/wholesale/online/export sales – please ensure that these are analysed separately in the accounts.
  • Growth potential – for example if you are not doing many of the services, the buyer will see this as an opportunity to enhance business and this is an attractive proposition for the buyer.


Interest rates and buyers’ appetite

The banks have maintained the level of lending appetite despite the rise in interest rates and economic pressures. We are pleased to report that most of our recent completion were to first time buyers which leads us to believe that they have a strong desire to acquire good, solid and profitable businesses. To facilitate their lending, many of the banks that are active in the pharmacy market are seeking increased due diligence, business plans, personal guarantee etc.


The table below shows interest rates at their peak, and the prediction for 2024 through to 2027 (source Bank of England).

Other news

We have been busy attending the Chemist + Druggist, Pharmacy Business and AIMp awards as well as exhibiting at The Pharmacy Show. It was nice to see our clients, prospects, colleagues and many familiar faces within community pharmacy attending those events. We look forward to attending the

same next year.


Thinking of selling or buying?

If you would like a free valuation or talk about how you could achieve a fantastic price for your pharmacy, please do contact us on our direct dial numbers: 020 7380 3446 or 020 7380 3424 and ask for Sanja or Diana in the first instance. We would welcome the opportunity to have a chat with you.


Alternatively, if you would like to buy a pharmacy, need accounting, or tax advice through our associated company Silver Levene, please also contact us on the same numbers. Your query will be directed to the right person.


Finally, we wish you a Merry Christmas, and a Happy, Healthy and Peaceful New Year. We look forward to talking to you soon.


This article is based on current legislation and practice and is for guidance only. Specific professional advice should be taken before acting on matters mentioned here. Should you require any advice please do not hesitate to contact us.

By Sanja Milosevic July 31, 2025
We trust you are enjoying the warm weather as we welcome you to our Summer Newsletter! Pharmacy market and selling activity The trend in the pharmacy sales market shows a continued activity with a mix of buyers and sellers, including large multiples and independent owners. We have seen large multiples disposing branches and there’s also a rise in first time buyers and small and mid-sized groups acquiring. Pharmacy contract and increase in funding The March 2025 funding deal looks promising and much needed boost for community pharmacies and a step in right direction compared to previous years. The Community Pharmacy Contractual Framework (CPCF) budget is to £3.073 billion for the 2025 / 2026 financial year, which will provide an uplift of over 30% compared to previous year. Additionally, an extra £215 million will be directed towards expanding existing Pharmacy First and other services. (Source: Community Pharmacy England) Outlook for pharmacies · Uncertainty in the budget – the upcoming autumn budget is expected to influence future activity in the pharmacy sales market. · Integration of technology and AI – technology, including AI and automation is playing a larger role in pharmacy operations and customer experience. · Growing role of pharmacies – pharmacies are taking on a larger role which may lead to further changes in the market. Factors influencing the sales market · Government policies – government regulations, particularly around funding and potential changes to CGT rules, can impact buying and selling decisions. · Economic growth and healthcare spending – increasing healthcare spending and an aging population are driving demand for pharmacy services. · Online pharmacy growth – the online pharmacy market is expanding, with companies like Pharmacy2U and others gaining market share. · Competition from online pharmacies – online pharmacies are becoming more popular, which may affect the traditional pharmacy model. Simplifying the sale of pharmacy and our checklist for a successful sale Selling a pharmacy can be daunting due to regulatory, financial and operational factors, but with the right strategy, we can help you streamline the process and avoid common pitfalls. Here is our recommendation for a smoother sale: - 1. Prepare early and get organised – collate key documents for the sale such as accounts, FP34s, VAT, returns, lease agreements, staff contract and compliance certificates. 2. Valuation – use pharmacy specialist agents to assess the value of your pharmacy based on profit multiples, dispensing volume etc (EBITDA workings). 3. Decide on the sale type – asset sale or company share sale where your accountant will be best to guide you. 4. Choose the right advisors – Broker helps you market the pharmacy and find a buyer. Please consider appointing a pharmacy specialist accountant and solicitor who have expertise to guide you through the whole sale process to completion. 5. Marketing the pharmacy – appoint a pharmacy specific broker such as Modiplus who will market your pharmacy in confidence and discreet. All buyers are vetted for funding and sign our confidentiality agreement allowing them to share sales information only with the bank, their accountant and solicitor. 6. Due diligence – you will be asked to use digital data rooms to share financials, FP34s, supplier contracts etc. Be transparent to disclose everything upfront to avoid delays or warranty claims. 7. Handle property efficiently – if leased, ensure that there’s at least 10 years left or obtain an extension. If freehold owned, prepare to sale the freehold or grant a new lease to the buyer. Please ensure lease terms meet buyer’s lender requirements. 8. Navigate NHS and GPhC requirements – For an asset sale, buyer must apply for transfer of NHS contract which usually takes between 2 to 4 months. For a share sale, no NHS approval is needed, however, notify NHS and GPhC of director / superintendent changes within 30 days. 9. Completion and handover – sign a Sale Purchase Agreement (SPA) or an Asset Purchase Agreement (APA), and hand over to the buyer. Other exciting news As we continue to grow, we are pleased to announce that our associated company Silver Levene was acquired by Xeinadin Group , a top 20 accountancy and business advisory firm in the UK. We highly recommend their pharmacy team of accountants with over 35 years of experience providing specialist accounting, tax and other advisory services to community pharmacies and pharmacists. For more information, please contact the pharmacy partners Mr Vinku Shah or Mr Shivam Modi on 020 7383 3200. Looking further ahead, we will be at The Pharmacy Show at NEC Birmingham on 12 and 13 October 2025 . If you are thinking of selling or buying a pharmacy, or looking for specialist pharmacy accountancy and tax advice, our team will be happy to discuss options with you at stand number M20 located next to the business theatre. Last month we participated with our associated company Silver Levene – A Xeinadin Company in the annual 10km London Legal Walk. The charity raised c£1m to support communities’ most vulnerable people and we thank you for your continued donations to support such a good cause. Legal and financial advisors Please engage a pharmacy specialist legal and financial advisor who will guide you through the process and assist you with any complex issues such as tax, legal contracts, etc. If you would like to sell/buy a pharmacy, need accounting or tax advice through our associated company Silver Levene – A Xeinadin Company, please contact us on 020 7383 3200. We have been providing specialist accounting and tax advisory services to community pharmacy for over 35 years. Your query will be directed to the right person. Silver Levene - A Xeinadin Company offers fixed price packages for accounting and tax services as well as valuations, cashflow and profit forecasts, raising loan finance, due diligence and accountancy work for asset and company sale transactions. Thinking of selling or buying? If you would like a free valuation or to talk about how you could achieve a fantastic price for your pharmacy, please do contact us on our direct dial number 020 7380 3446 and ask for Sanja . We would welcome the opportunity to have a chat with you. We look forward to hearing from you. This article is based on current legislation and practice and is for guidance only. Specific professional advice should be taken before acting on matters mentioned here.
By Modiplus February 26, 2025
Welcome to our Winter Newsletter! Pharmacy market trend and buyers’ appetite If you are thinking of selling your pharmacy, there is still a demand for pharmacies across the country as the market remains buoyant. The pharmacy market has seen an increase in the number of pharmacies entering the market and completed sales. This is driven by economic pressures, fiscal policies, lack of funding, and exit of larger multiples from the market, such as Lloyds Pharmacy and Boots, which has led to the rise of independents and consolidations. The appetite remains strong from the first-time buyers, with independent and smaller chains the most active in the pharmacy acquisitions. Valuation calculations We have also seen the valuation of pharmacies improving, and on average we are achieving a goodwill price of 85p to 90p in £1 of turnover for standard hour contracts. Demand for pharmacies with a turnover of more than £750k to £1.5m with healthy profits is particularly attractive for the first-time acquisitions or an existing independent operator looking to expand. Below is a range of estimated valuations, if you are looking to sell: -
By Modiplus August 29, 2024
Welcome to our Summer Newsletter and we trust that you are enjoying the late summer weather! This summer has been extraordinary so far, full of sporting events such as football, tennis, cricket and the Olympic games! We have been very busy in the last quarter, whereby we have seen the first-time buyer appetite remain strong. Similarly, we have seen an increase in the number of sales enquiries of smaller pharmacies while others are holding off awaiting the outcome of the new funding and success of Pharmacy First scheme. On average we are achieving goodwill price of between 85p to 90p in £1 of turnover at present. The average profit margin has shown an improvement to 32% despite medicine shortages. Data from Pharmacy First (NHSBSA) The launch of the Pharmacy First has gone off with a positive start, it has been very encouraging to see so many patients benefiting from this scheme, and your exceptional efforts in delivering these services have been commendable. However, we note that monthly payments are still critical, and concur that it is completely unreasonable for pharmacy to be penalised financially for the NHS’ failure to drive public and GP referrals. The NHS Business Services Authority (NHSBSA) has released figures for the Pharmacy First Service covering the period of February to April 2024 as follows: -